• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

tildra

  1. Ilumya Meeting Registration??

    Anyone hear if we are still going to meeting? My RSM says Princeton is finalizing “details” and then travel will re-open for us to book. Last email I rec’d was some people may have to come in earlier or something but rest of us would book next day? Who knows at this point. NOONE WANTS TO GO for...
  2. Ilumya East Region RSM

    Take this as however you want it but when I was sold the promise of owning my territory, making a difference, and a nice salary to provide for my family I had no idea I was selling my soul to the most incompetent RSM who undermines my every effort, plays favorites, likes to make life hell for...
  3. Ilumya TMs do you know what unethical behavior means?

    A bit of advice to senior leadership is keep close watch on a few of your TMs before Sun gets dragged through compliance hell & more bad press. Did I miss part during Hub training call where we can fill out patient enrollment forms for office with patient info, maybe even sign them, and fax in...
  4. Tilda Dead before Launch, Patient Death

    DEATH and terrible data, good luck, oh my! reSURFACE 1, at week 12, a PASI75 was acheived in 62% in the 200 mg group and 64% in the 100 mg group compared with 6% in the placebo group (p<0·0001 vs placebo). In reSURFACE 2, a PASI75 was seen 66% in the 200 mg group, 61% in the 100 mg group, and...